Pfizer Income from Discontinued Operations 2010-2024 | PFE

Pfizer income from discontinued operations for the twelve months ending December 31, 2024 was $11M, a 173.33% decline year-over-year.

  • Pfizer annual income from discontinued operations for 2024 was $0.011B, a 173.33% decline from 2023.
  • Pfizer annual income from discontinued operations for 2023 was $-0.015B, a 350% decline from 2022.
  • Pfizer annual income from discontinued operations for 2022 was $0.006B, a 101.38% decline from 2021.

Pfizer Income from Discontinued Operations 2010-2024 | PFE

  • Pfizer annual income from discontinued operations for 2024 was $0.011B, a 173.33% decline from 2023.
  • Pfizer annual income from discontinued operations for 2023 was $-0.015B, a 350% decline from 2022.
  • Pfizer annual income from discontinued operations for 2022 was $0.006B, a 101.38% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B